Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1.

Acta Ophthalmol · 2022 · PMC9298034 · PMID 34672100

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Furthermore, the 95% confidence interval lower limit indicates that a clinically highly significant lower hypermetropia for a double dose of cyclopentolate 1% may exist.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.